Medical societies representing all three specialties issued a joint statement Jan. 21, criticizing studies claiming such scans pose risk of potential patient harm.
The Healthcare Leadership Council—a forum for C-suite leaders across different industries—recently released the results of a new survey of its members.
The added indications make the treatment the first Y-90 therapy approved for both unresectable hepatocellular carcinoma and metastatic colorectal cancer of the liver.
Leaders with the Raleigh, North Carolina-based radiology group said the change comes as the practice continues pursuing expansion through "de novo" imaging centers.
The Deerfield Beach, Florida-based company is adding MetisMD, “a highly regarded teleradiology provider with deep expertise in musculoskeletal imaging.”
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.